Optimization of protein crosslinking formulations for the treatment of degenerative disc disease

Spine

Volumn 36, Issue 1, 2011, Pages

  Slusarewicz, Paul ^a   Zhu, Keng ^a   Kirking, Bryan ^a,b   Toungate, Justin ^a   Hedman, Tom ^a,b  

^a Orthopeutics LP   (United States)

^b Texas A M University   (United States)

Author keywords

crosslinking; Degenerative disc disease; genipin; methylglyoxal; therapeutic

Indexed keywords

DODECYL SULFATE SODIUM; GENIPIN; METHYLGLYOXAL; PHOSPHATE; POLYSORBATE 20; SURFACTANT;

ANIMAL TISSUE; ARTICLE; BIOMECHANICS; COW; CROSS LINKING; DEGENERATIVE DISEASE; DIFFUSION; DRUG FORMULATION; INTERVERTEBRAL DISK HERNIA; NONHUMAN; PRIORITY JOURNAL; TENSILE STRENGTH; YOUNG MODULUS;

ANIMALS; BIOMECHANICS; CATTLE; CROSS-LINKING REAGENTS; DIFFUSION; INJECTIONS, SPINAL; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; IRIDOID GLYCOSIDES; LUMBAR VERTEBRAE; POLYSORBATES; PYRUVALDEHYDE; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; TENSILE STRENGTH; TIME FACTORS;

EID: 78751591278     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181cc3de9     Document Type: Article

References (42)

1. Adams MA, Roughley PJ. What isintervertebral disc degeneration, and what causes it? Spine 2006;31:2151-61.
2. Katz JN. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am 2006;88(suppl 2):21-4.
3. Urban JP, Smith S, Fairbank JC. Nutrition of the intervertebral disc. Spine 2004;29:2700-9.
4. Gu WY, Mao XG, Foster RJ, et al. The anisotropic hydraulic permeability of human lumbar anulus fi brosus. Influence of age, degeneration, direction, and water content. Spine 1999;24:2449-55.
5. Kitano T,Zerwekh JE, Usui Y, et al. Biochemical changes associated with the symptomatic human intervertebral disk. Clin Orthop Relat Res 1993:372-7.
6. Schnake KJ, Putzier M, Haas NP, et al. Mechanical concepts for disc regen eration. Eur Spine J 2006;15(suppl 3):S354-60.
7. Masuda K, An HS. Prevention of disc degeneration with growth factors. Eur Spine J 2006;15(suppl 3):S422-32.
8. Sobajima S, Kim JS, Gilbertson LG, et al. Gene therapy for degenerative disc disease. Gene Ther 2004;11:390-401.
9. Acosta FL Jr, Lotz J, Ames CP. The potential role of mesenchymal stem cell therapy for intervertebral disc degeneration: a critical overview. Neurosurg Focus 2005;19:E4.
10. Chuang SY, Odono RM, Hedman TP. Effects of exogenous crosslinking on in vitro tensile and compressive moduli of lumbar intervertebral discs. Clin Biomech 2007;22:14-20.
11. Hedman TP, Saito H, Vo C, et al. Exogenous cross-linking increases the stability of spinal motion segments. Spine 2006;31:480-5.
12. Wagner DR, Reiser KM, Lotz JC. Glycation increases human annulus fi brosus stiffness in both experimental measurements and theoretical predictions. J Biomech 2006;39:1021-9.
13. Yerramalli CS, Chou AI, Miller GJ, et al. The effect of nucleus pulposus crosslinking and glycosaminoglycan degradation on disc mechanical func tion. Biomech Model Mechanobiol 2007;6:1 3-20.
14. Cochrane SM, Robinson GB. In vitro glycation of glomerular basement membrane alters its permeability: a possible mechanism in diabetic compli cations. FEBS Lett 1995;375:41-4.
15. Boyd-White J, Williams JC Jr. Effect of cross-linking on matrix permeability. A model for AGE-modifi ed basement membranes. Diabetes 1996;45:348-53.
16. Hedman T, Saito H, Chuang SY. Matrix modification increases hydraulic permeability of the annulus fi brosus. Orthop Trans 2006;31:1241.
17. Hoffmann B, Seitz D, Mencke A, et al. Glutaraldehyde and oxidised dextran as crosslinker reagents for chitosan-based scaffolds for cartilage tissue engi neering. J Mater Sci Mater Med 2009; 20:1495-503.
18. Han B, Jaurequi J, Tang BW, et al. Proanthocyanidin: a natural crosslinking reagent for stabilizing collagen matrices. J Biomed Mater Res A 2003;65:118-24.
19. Gratzer PF, Lee JM. Control of pH alters the type of cross-linking produced by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) treatment of acellular matrix vascular grafts. J Biomed Mater Res 2001;58:172-9.
20. Verzijl N, De Groot J, Ben ZC, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteo-arthritis. Arthritis Rheum 2002;46:114-23.
21. Sung HW, Liang IL, Chen CN, et al. Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin). J Biomed Mater Res 2001; 55:538-46.
22. Slusarewicz P, Zhu K, Hedman T. Kinetic characterization and comparison of various protein crosslinking reagents suitable for tissue engineering. J Mater Sci Mater Med 2010;21:1175-81.
23. Sung HW, Chang Y, Chiu CT, et al. Crosslinking characteristics and me chanical properties of a bovine pericardium fixed with a naturally occurring crosslinking agent. J Biomed Mater Res 1999;47:116-26. (Pubitemid 29409731)
24. Peters MA, Hudson PM, Jurgelske W Jr. The acute toxicity of methylglyoxal in rats: the influence of age, sex, and pregnancy. Ecotoxicol Environ Saf 1978;2:369-74.
25. Sung HW, Huang RN, Huang LL, et al. In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Ed 1999;10:63-78.
26. Touyama R,InoueK,Takeda Y, et al. Studiesonthe blue pigments produced from genipin and methylamine. II. On the formation mechanisms of brown ish-red intermediates leading to the blue pigment formation. Chem Pharm Bull 1994;42:1571-8.
27. Touyama R, Takeda Y, Inoue K, et al. Studies on the blue pigments produced from genipin and methylamine. I. Structures of the brownish-red pigments, intermediates leading to the blue pigments. Chem Pharm Bull 1994;42:668-73. (Pubitemid 24156290)
28. Ohno K, Yasuhara K, Kawasaki Y, et al. Comparative studies on acute toxicity of glutaraldehyde using young and old rats [in Japanese]. Eisei Shikenjo Hokoku 1991:92-7.
29. Bannister DW, Burns AB. Adaptation of the Bergman and Loxley technique for hydroxyproline determination to the autoanalyzer and its use in determining plasma hydroxyproline in the domestic fowl. Analyst 1970;95:596-600.
30. Berg RA. Determination of 3- and 4-hydroxyproline. Methods Enzymol 1982;82(Pt A):372-98.
31. Prockop DJ, Udenfriend S, Lindstedt S. A simple technique for measuring the specific activity of labeled hydroxyproline in biological materials. J Biol Chem 1961;236:1395-8.
32. Reddy GK, Enwemeka CS. A simplifi ed method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996;29: 225-9.
33. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967;18:267-73.
34. Murata-Kamiya N, Kamiya H. Methylglyoxal, an endogenous aldehyde, crosslinks DNA polymerase and the substrate DNA. Nucleic Acids Res 2001;29:3433-8.
35. Sung HW, Chang Y, Liang IL, et al. Fixation of biological tissues with a natu rally occurring crosslinking agent: fixation rate and effects of pH, temperature, and initial fixative concentration. J Biomed Mater Res 2000;52:77-87.
36. Diamant B, Karlsson J, Nachemson A. Correlation between lactate levels and pH in discs of patients with lumbar rhizopathies. Experientia 1968;24: 1195-6.
37. Kallet RH, Jasmer RM, Luce JM, et al. The treatment of acidosis in acute lung injury with tris-hydroxymethyl aminomethane (THAM). Am J Respir Crit Care Med 2000;161:1149-53.
38. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001;56:1-21.
39. Watkins NG, Neglia-Fisher CI, Dyer DG, et al. Effect of phosphate on the kinetics and specificity of glycation of protein. J Biol Chem 1987;262:7207-12.
40. De Groot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 2004;4:301-5.
41. Yamano T, Tsujimoto Y, Noda T, et al. Hepatotoxicity of gardenia yellow color in rats. Toxicol Lett 1988;44:177-82.
42. Cheung KM, Chan D, Karppinen J, et al. Association of the Taq I allele in vitamin D receptor with degenerative disc disease and disc bulge in a Chinese population. Spine 2006;31:1143-8.